Helix Acquisition Corp. III (HLXC) Prices Upsized $150M IPO
Helix Acquisition Corp. III (NASDAQ:HLXC) announced the pricing of its upsized $150 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “HLXC”, Friday, January 23, 2026.
The new SPAC aims to combine with a healthcare or healthcare-related company that may benefit from its sponsor’s expertise in scaling through that industry.
Helix III’s management team is led by Chairperson and Chief Executive Officer Bihua Chen, Chief Financial Officer and Chief Operating Officer Caleb Tripp, and Chief Legal Officer Nebojsa Obradovic. The Board also includes Directors John Schmid and Mark McKenna.
Total SPAC deal count for 2026 year-to-date is now 13. This offering is expected to close on Monday, January 26, 2026.
Leerink Partners and Oppenheimer & Co. are acting as joint book-running managers for the offering. White & Case LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
